| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3704fd87f9567251ff29be731359607 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fab28ee480a25d90e7c72746b6a7e3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4556cbf9115b83a5b53f38bbc7af1fe0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a9036e1b58f0439250d5a2fd5762648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8283f9ec01d1bf212e38d2d2e633d808 |
| publicationDate |
2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016279077-A1 |
| titleOfInvention |
Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders |
| abstract |
The present invention relates to compressed tablets for peroral delivery of the cannabinoid cannabidiol (CBD). More particularly, the invention provides a compressed tablet having a tablet weight of 60-1200 mg, said tablet being composed of: 50-95 wt. % of a granulate; 5-50 wt. % of lactose; and 0-30 wt. % of other tablet excipients; wherein the granulate contains: a.2-15 wt. % of cannabidiol; b.2-30 wt. % of sucrose fatty acid mono-ester; c.30-96 wt. % of lactose; and d.0-25 wt. % of other granulate excipients. The compressed tablets according to the invention can conveniently be used in the treatment of psychosis disorders or anxiety disorders. The invention further provides a method for the manufacture of the compressed tablets. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11273122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7360526-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112043672-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019201347-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179340-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10307392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019133879-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3351118-A1 |
| priorityDate |
2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |